Is Tarsus Pharmaceuticals, Inc. (TARS) a Buy, Sell, or Hold?
NASDAQ : TARS
Tarsus Pharmaceuticals, Inc. — Institutional Ownership
$61.29 USD
$0.18 (0.29%)
- Volume
- 333.23K
- Average Volume
- 971K
- Market Capitalization
- $2.64B
- P/E Ratio
- -53.76
- Dividend Yield
- 0.00%
- Price Target
- $93.50
- Year High
- $85.25
- Year Low
- $40.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.74
Institutional Ownership Summary
Institutional Ownership %
9.37%
Investors Holding
56
change: -204.0 | last: 260
Increased Positions
27
change: -110.0 | last: 137
Reduced Positions
18
change: -64.0 | last: 82
New Positions
7
change: -40.0 | last: 47
Sold Positions
206
change: 166.0 | last: 40
Total Calls
3300
Total Puts
1000
Put-Call Ratio
0.30
change: -46.0272 | last: 0.7633
Total Invested
253.36M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Deep Track Capital, LP | 3.6M | 8.46% |
| 2026-05-15 | JANUS HENDERSON GROUP PLC | 2.24M | 5.30% |
| 2026-05-08 | PRUDENTIAL FINANCIAL INC | 1.84M | 4.30% |
| 2026-05-06 | Jennison Associates LLC | 1.71M | 4.00% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | TANG CAPITAL MANAGEMENT, LLC | 1.19M | 2.80% |
| 2025-11-14 | Deep Track Capital, LP | 3M | 7.11% |
| 2025-08-14 | RTW Investments, LP | 3.42M | 8.10% |
| 2025-07-28 | Deep Track Capital, LP | 2.35M | 5.60% |
| 2025-05-15 | TANG CAPITAL MANAGEMENT, LLC | 2.45M | 5.90% |
| 2025-05-07 | Morgan Stanley | 1.94M | 4.70% |
| 2025-04-24 | BlackRock, Inc. | 3.09M | 7.40% |
| 2025-02-13 | Cowen Financial Products LLC | 1.91M | 4.90% |
| 2024-02-09 | Morgan Stanley | 1.94M | 5.90% |
| 2024-01-22 | Paradigm BioCapital Advisors LP | 1.93M | 5.80% |
| 2024-01-22 | Senai Asefaw, M.D. | 1.93M | 5.80% |
| 2024-01-22 | Paradigm BioCapital Advisors GP LLC | 1.93M | 5.80% |
| 2024-01-22 | Paradigm BioCapital International Fund Ltd. | 1.64M | 5.00% |
| 2023-02-09 | (1) BlackRock, Inc. | 1.33M | 4.90% |
| 2023-02-08 | (1) BlackRock, Inc. | 1.34M | 5.00% |
| 2023-02-03 | 20-1665304 | 1.43M | 5.36% |
| 2022-05-11 | James E. Flynn | 1.32M | 5.04% |
| 2022-05-11 | Deerfield Mgmt, L.P. | 1.32M | 5.04% |
| 2022-05-11 | Deerfield Partners, L.P. | 1.32M | 5.04% |
| 2022-05-11 | Company, L.P. | 1.32M | 5.04% |
| 2022-02-14 | Bihua Chen | 1.4M | 6.79% |
| 2022-02-14 | Cormorant Private Healthcare Fund III, LP | 351.85K | 1.70% |
| 2022-02-14 | Cormorant Private Healthcare GP III, LLC | 351.85K | 1.70% |
| 2022-02-14 | Cormorant Asset Management, LP | 1.4M | 6.79% |
| 2022-02-14 | Cormorant Global Healthcare Master Fund, LP | 764.56K | 3.70% |
| 2022-02-14 | Cormorant Private Healthcare Fund II, LP | 281.42K | 1.36% |
| 2022-02-14 | Michael Ackermann | 1.26M | 6.10% |
| 2022-02-14 | Cormorant Global Healthcare GP, LLC | 764.56K | 3.70% |
| 2022-02-14 | Cormorant Private Healthcare GP II, LLC | 281.42K | 1.36% |
| 2021-02-16 | 2 | 1.3M | 6.40% |
| 2021-02-16 | Joseph Edelman | 1.3M | 6.40% |
| 2021-02-16 | Flying L Investments XI, LLC | 1.21M | 5.88% |
| 2021-02-12 | RTW Master Fund, Ltd. | 1.58M | 7.78% |
| 2021-02-12 | Michael Ackermann | 1.47M | 7.07% |
| 2021-02-12 | Roderick Wong | 2.46M | 12.13% |
| 2021-02-12 | Bobak Azamian | 1.92M | 9.04% |
| 2021-02-12 | RTW Investments, LP | 2.46M | 12.13% |
| 2020-10-30 | Cormorant Private Healthcare Fund II, LP | 281.42K | 1.40% |
| 2020-10-30 | Cormorant Asset Management, LP | 1.96M | 9.78% |
| 2020-10-30 | Horowitz Management, Inc. | 1.92M | 10.00% |
| 2020-10-30 | Adam S. Horowitz Revocable Trust | 66172.0 | 0.30% |
| 2020-10-30 | Jason E. Tester | 1.95M | 10.10% |
| 2020-10-30 | Cormorant Private Healthcare GP II, LLC | 281.42K | 1.40% |
| 2020-10-30 | Cormorant Global Healthcare Master Fund, LP | 1.27M | 6.33% |
| 2020-10-30 | Bihua Chen | 1.96M | 9.78% |
| 2020-10-30 | Cormorant Private Healthcare Fund III, LP | 351.85K | 1.75% |
| 2020-10-30 | Cormorant Global Healthcare GP, LLC | 1.27M | 6.33% |
| 2020-10-30 | Cormorant Private Healthcare GP III, LLC | 351.85K | 1.75% |
| 2020-10-30 | Horowitz Limited Partnership VIII | 1.99M | 10.30% |
| 2020-10-28 | Vivo Capital IX, LLC | 3.25M | 16.20% |
| 2020-10-26 | RTW Investments, LP | 2.46M | 12.79% |
| 2020-10-26 | Roderick Wong | 2.46M | 12.79% |
| 2020-10-26 | RTW Master Fund, Ltd. | 1.58M | 8.20% |
| 2020-10-23 | James Topper | 1.92M | 9.50% |
| 2020-10-23 | Patrick Heron | 1.92M | 9.50% |
| 2020-10-23 | Frazier Life Sciences IX, L.P. | 1.92M | 9.50% |
| 2020-10-23 | FHMLS IX, L.P. | 1.92M | 9.50% |
| 2020-10-23 | FHMLS IX, L.L.C. | 1.92M | 9.50% |
TARS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $81.88 | 41.78M | $3.42B | $183.64M | $93.64M | $3.33B |
| 2024-12-31 | $55.37 | 37.6M | $2.08B | $94.82M | $72.45M | $2.06B |
| 2023-12-31 | $20.25 | 29.38M | $595.01M | $224.95M | $30.22M | $400.28M |
| 2022-12-31 | $14.66 | 24.62M | $360.92M | $71.66M | $20.21M | $309.47M |
| 2021-12-31 | $22.50 | 20.55M | $462.47M | $171.33M | $1.89M | $293.03M |
| 2020-12-31 | $41.33 | 20.32M | $839.96M | $168.13M | $831K | $672.66M |
| 2019-12-31 | $20.58 | 19.51M | $401.5M | $57.95M | $164K | $343.71M |
| 2018-12-31 | $20.58 | 4.29M | $88.19M | $2.36M | -$ | $85.84M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $70.15 | 42.96M | $3.01B | $102.19M | $88.68M | $3B |
| 2025-12-31 | $81.88 | 42.78M | $3.5B | $183.64M | $93.64M | $3.41B |
| 2025-09-30 | $59.43 | 42.61M | $2.53B | $112.72M | $82.51M | $2.5B |
| 2025-06-30 | $40.51 | 42.36M | $1.72B | $96.65M | $72.45M | $1.69B |
| 2025-03-31 | $51.37 | 39.35M | $2.02B | $175.79M | $72.37M | $1.92B |
| 2024-12-31 | $55.37 | 38.56M | $2.14B | $94.82M | $72.45M | $2.11B |
| 2024-09-30 | $32.89 | 38.38M | $1.26B | $176.21M | $72.34M | $1.16B |
| 2024-06-30 | $28.24 | 37.82M | $1.07B | $181.1M | $72.18M | $959.22M |
| 2024-03-31 | $35.85 | 35.3M | $1.27B | $193.7M | $30.52M | $1.1B |
| 2023-12-31 | $20.25 | 31.94M | $646.87M | $224.95M | $30.22M | $452.14M |
| 2023-09-30 | $17.77 | 30.62M | $544.16M | $226.67M | $30.13M | $347.62M |
| 2023-06-30 | $18.07 | 26.82M | $484.56M | $106.77M | $25.04M | $402.83M |